
CATrends: Deceptive Influencer Marketing
It’s a hot sponcon summer.
A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca. They claimed that the pharmaceutical company deceptively marketed the medication as superior to its other heartburn drugs so that consumers would buy the more expensive Nexium. In October 2012, AstraZeneca agreed to settle the lawsuit but the terms of the settlement have not yet been announced. (Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Case No. 05-0269)
It’s a hot sponcon summer.
What’s this reservation good for?
TINA.org continues to support FTC, New York in federal court.
A bogus connection to major retailers is just the beginning.
Don’t pay for free online government forms.